Skip to main content
Clinical Trials/NCT01790763
NCT01790763WithdrawnPhase 2

Prospective,Randomized, Parallel Study to Compare the Efficacy of Mepilex and Keramatrix in Promoting Healing of Second Degree Burn Wounds

The University of Texas Medical Branch, Galveston2 sites in 1 countryStarted: April 2015Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Withdrawn
Locations
2
Primary Endpoint
Wound Healing

Study Overview

Brief Summary

The purpose of this study is to determine the extent to which Keramatrix dressing promotes the healing of second-degree burn wounds in pediatric patients.

Detailed Description

Efficacy in promoting wound healing will be determined through comparison to Mepilex, an established burn wound dressing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
1 Day to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient age 0-18 years old Flame or scald burn 10-30% total body surface area burned Partial-thickness second-degree burns Admission within 72 hours of burn injury Clean non-infected wound as diagnosed by the attending physician

Exclusion Criteria

  • Patient older than 18
  • Causes other than flame or scald injuries (ie.chemical or frostbite)
  • Wounds noted to be contaminated or infected
  • Patients who have received previous treatment efforts (topical dressings or previous wound debridement)
  • Pregnancy lactation
  • Co-morbidity which may compromise healing: known history of AIDS, ARC, HIV, cancer, autoimmune diseases,cirrhosis, tuberculosis, chronic glucocorticoid therapy, diabetes mellitus, renal insufficiency, hepatic disease, congestive heart failure prior to burn injury, associated severe head injury requiring specific treatment
  • known allergy to sheep's wool

Outcomes

Primary Outcomes

Wound Healing

Time Frame: Duration of hospital stay, an expected average of 0.75 days per every percent burn until wound heals

Wound healing will be determined by measuring wound surface area. Wound surface area will be determined through planimetry, which will be performed on digital photographs of the wounds.

Secondary Outcomes

  • Scarring(52 weeks up to 78 weeks)
  • Infection rates(Duration of hospital stay, an expected average of 0.75 days per percent burn until wound heals)
  • Pain(duration of hospital stay, an expected average of 0.75 days per every percent burn until wound heals, up to 3 times a week during dressing changes)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Compare the Efficacy of Mepilex and... | Clinical Trial